Credit Suisse
-
Samsung Biologics has sent out a request for proposals for an up to W3tr ($2.6bn) listing in South Korea, according to a source close to the situation. -
-
Samsung Biologics Co will send out a request for proposals next week for its 2016 IPO, expected to fetch over W3tr ($2.6bn), a source close to the situation told GlobalCapital Asia.
-
Dominican Republic-based power generator AES Dominicana will begin investor meetings on Friday ahead of a proposed dollar denominated 144A/Reg S as Lat Am corporates revelled in strong market conditions.
-
UBI Banca became the first Italian lender to print tier two capital this year on Wednesday, laying the foundations for more periphery capital to follow.
-
Global construction equipment maker Doosan Bobcat is looking to file for approval for its South Korea IPO by July and could list two months later, a source with knowledge of the situation told GlobalCapital Asia.
-
Just two working days after Numis’s dashing block trade in Saga stock on Thursday last week, Credit Suisse brought another sparky, sole-managed deal to the market on Monday night, with a £1bn sale of SABMiller shares for Jan Kulczyk, the Polish billionaire.
-
The block trade market is an exciting, risky part of the equity business. Banks can slip up — but that shows how hard they are competing for deals. If, as it seems, block trades work well for issuers and investors, regulators like the Financial Conduct Authority should not interfere.
-
Alibaba Group Holdings has wound up its latest five year bullet at an increased size of $4bn after attracting robust demand during general syndication.
-
Inovyn, the UK-headquartered chorvinyls (PVC) producer 50% owned by Ineos, has set price guidance on its €835m term loan ‘B’ backing its €335m buyout of equity partner Solvay.
-
Taghleef, the Dubai-based food packaging film maker owned by Al Ghurair Group, has tightened pricing on its €285m-equivalent seven year term loan ‘B’ to a margin of 450bp, offered at 99.
-
The European Central Bank’s (ECB) decision to include insurance companies in its Corporate Sector Purchase Programme (CSPP), helped JP Morgan’s Sfr200m bond on Friday, allowing undersupplied Swiss investors a chance to buy.
